Study of Shatavari Ghrita Preparation and Its Effect on hyperacidity and Indigestion (Amlapitta) in Patients

Preparation and pharmaceutical analysis of Shatavari Ghrita and its effect on Amlapitta - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111824

Enrollment

Registered

2026-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient welling for trail and give written informed consent. 2.selected sign and symptom based on both ayurvedic and allopathic context

Exclusion criteria

Exclusion criteria: age below 21 year and above 60 years patient having any systematic illness like Tb hepatitis B AIDS etc pregnant women and lactating women patient suffering from duodenal ulcers patient suffering from peptic ulcers

Design outcomes

Primary

Measure	Time frame
to evaluate the effect of Shatavari Ghrita on Amlapitta (hyperacidity)Timepoint: 30 days	—

Secondary

Measure	Time frame
1.improvement in individual clinical symptom of Amlapitta. 2.pharmaceutical and physiochemical standardization of shatavari ghritaTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Ravish Chandra Sinha

Government ayurvedic college

sumeshwarsingh.1959@gmail.com9431881708

Outcome results